Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.70%
+16.27%
-6.18%
+21.12%
Most Trending
+2.70%
+16.27%
-6.18%
+21.12%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
05 Nov 2025$SLDP Solid Power surged past its 52-week high after beating EPS and revenue estimates. Volume spiked nearly 4x average as investors piled in. Uptrend remains strong.
$VALE Vale hit new yearly highs after positive analyst commentary and stronger iron ore outlook. RSI signals overbought, but momentum buyers remain active.
$BW Babcock & Wilcox exploded 30% after unveiling a $1.5B AI data center project. Heavy volume confirms strong breakout energy and renewed investor interest.
$WBD Warner Bros. Discovery broke above resistance ahead of earnings. Despite mixed analyst sentiment, traders are positioning for a rebound in streaming demand.
$LMND Lemonade jumped after reporting solid earnings and raised guidance. RSI near 76 shows it’s hot, but bulls are holding firm as fintech optimism grows.
$LITE Lumentum soared after an earnings beat and stronger outlook. The move above $237 signals tech momentum returning to the optical space.
$CSIQ Canadian Solar hit new highs on strong sector tailwinds. Solar demand and analyst upgrades continue to fuel momentum.
$JCI Johnson Controls pushed higher after solid quarterly results and exposure to the growing data center market. Strong volume confirms institutional interest.
$WDC Western Digital extended gains on AI-related storage demand. The stock’s fresh high signals continued investor confidence in data infrastructure.
$ROIV Roivant Sciences hit new highs as biotech names stay strong. RSI above 80 shows heavy accumulation in the sector.
$STX Seagate Technologies continues its rally, hitting another high on AI hardware optimism and improved profitability outlook.
$LLY Eli Lilly keeps soaring, pushing near $950 after upbeat trial data and a strong pharma pipeline. Trend remains unstoppable.
$RPRX Royalty Pharma broke to new highs despite softer results, as investors look ahead to its long-term royalty pipeline strength.
$LRCX Lam Research reached a new 52-week high after multiple price target hikes. Semiconductor optimism and AI chip growth keep momentum alive.
$CTMX CytomX Therapeutics extended its winning streak, breaking through prior highs as biotech enthusiasm spreads.
$FSLR First Solar stays bright, reaching $279 with strong volume. RSI elevated, but institutional demand remains strong.
$LVS Las Vegas Sands climbed above $62 on sustained travel strength. Uptrend intact as consumers keep spending.
$NBIX Neurocrine Biosciences continues climbing on analyst optimism and strong fundamentals. RSI near 70 but no signs of slowing.
$INCY Incyte rallied past $105 with RSI above 80. Biotech investors are chasing strength, expecting further continuation.
$CAH Cardinal Health hit new highs at $198 on defensive healthcare rotation and upbeat financial performance.
$COR Cencora climbed to all-time highs after a strong earnings report and raised guidance, confirming leadership in healthcare distribution.
$AEIS Advanced Energy hit fresh highs after exceeding earnings expectations. Semiconductor demand remains a key tailwind.
$TSEM Tower Semiconductor advanced to new highs amid rising chip demand and growing investor confidence post-merger fallout.
$VTR
Ventas inched to fresh highs after analysts reaffirmed positive outlooks on healthcare REITs.
$AER AerCap reached a new peak as investors return to aviation plays amid recovering global travel demand.
$MCK McKesson quietly broke higher again, continuing its long-term uptrend as healthcare stocks outperform.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
